title: Characterization of the contractile 5-hydroxytryptamine receptor in the renal artery of the normotensive rat.
abstract: Our goal was to characterize the 5-hydroxytryptamine (5-HT) receptor(s) mediating contraction in the isolated right renal artery, testing the hypothesis that the 5-HT(2A) receptor would be the primary and likely only 5-HT receptor involved in contraction. Contraction of arteries was investigated in isolated tissue baths, and expression of 5-HT receptors was measured using immunohistochemical and Western analyses. Compared with endothelium-denuded rat aorta, a tissue with an established 5-HT(2A) receptor, endothelium-denuded renal artery contracted to 5-HT with a 10-fold greater potency. Surprisingly, the 5-HT(2B) receptor agonist alpha-methyl-5-(2-thienylmethoxy)-1H-indole-3-ethanamine hydrochloride (BW723C86) caused a concentration-dependent contraction that was antagonized by the 5-HT(2B) receptor antagonist 6-methyl-1,2,3,4-tetrahydro-1-[3,4-dimethoxyphenyl) methyl-9H-pyrido[3,4b]indole] hydrochloride (LY272015) and nonselective 5-HT(2) receptor antagonist 6-methyl-1-(1-methylethyl)-ergoline-8b-carboxylic acid 2-hydroxy-1-methylpropyl ester maleate (LY53857). Correlation of -log EC(50) values with binding affinities (pK(i)) indicated that contraction of the renal artery elicited by 13 different agonists was likely consistent with activation of a 5-HT(2A) (r = 0.928) and 5-HT(2B) (r = 0.843) receptor. 5-HT-induced contraction was shifted by the 5-HT(2A) receptor antagonist ketanserin (3 and 10 nM) and the 5-HT(2B) receptor antagonist LY272015 (10 and 50 nM). Higher than expected concentrations of the 5-HT(2A)/5-HT(2B) receptor antagonist LY53857 were needed to antagonize 5-HT-induced contraction and the 5-HT(2B) receptor antagonist 2-amino-4-(4-fluoronaphth-1-yl)-6-isopropylpyrimidine (RS127445) was virtually inactive. Western and immunohistochemical analyses of the renal artery validated the presence of 5-HT(2A) and 5-HT(2B) receptor protein. These results suggest that the renal artery possesses a complex 5-HT receptor population, including ketanserin- and LY272015-sensitive receptors. This unique pharmacology may reflect differences in 5-HT receptor coupling between tissues or heterogeneity in the subtype(s) of 5-HT receptors expressed in the renal artery.
authors.affiliation: Department of Pharmacology and Toxicology, B445 Life Sciences Bldg., Michigan State University, East Lansing, MI 48824-1317. wattss@msu.edu
authors.forename: Stephanie W
authors.initials: SW
authors.lastname: Watts
authors.forename: Janice M
authors.initials: JM
authors.lastname: Thompson
mesh_terms: D000818:Animals; D001013:Aorta, Thoracic / Q000187:drug effects / Q000502:physiology; D066298:In Vitro Techniques; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D044402:Receptor, Serotonin, 5-HT2A / Q000032:analysis; D044403:Receptor, Serotonin, 5-HT2B / Q000032:analysis; D011985:Receptors, Serotonin / Q000187:drug effects / Q000378:metabolism*; D012077:Renal Artery / Q000187:drug effects* / Q000502:physiology; D012701:Serotonin / Q000494:pharmacology*; D012702:Serotonin Antagonists / Q000494:pharmacology; D017366:Serotonin Receptor Agonists / Q000494:pharmacology; D014661:Vasoconstriction / Q000187:drug effects*
chemical_list: D044402:Receptor, Serotonin, 5-HT2A; D044403:Receptor, Serotonin, 5-HT2B; D011985:Receptors, Serotonin; D012702:Serotonin Antagonists; D017366:Serotonin Receptor Agonists; D012701:Serotonin